This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Songu-Mize, E. Articles by Caldwell, R. W. Search for Related Content PubMed PubMed Citation Articles by Songu-Mize, E. Articles by Caldwell, R. W.

Hypertension, Vol 4, 575-580, Copyright © 1982 by American Heart Association

ARTICLES

Effect of AV3V lesions on development of DOCA-salt hypertension and vascular Na+-pump activity

E Songu-Mize, SL Bealer and RW Caldwell

We studied the effects of anteroventral third ventricle (AV3V) lesions on the vascular Na+-pump activity of deoxycorticosterone acetate-salt (DOCA-salt) treated rats. Blood pressures and Na+-pump activity of the isolated tail arteries, measured as ouabain-sensitive 86Rb-uptake, were determined in untreated control rats, DOCA-salt treated rats, rats with AV3V lesions, and rats with AV3V lesions which were treated with DOCA- salt. Control rats receiving DOCA treatment developed higher blood pressures than rats receiving no DOCA treatment. Placement of AV3V lesions prior to administration of DOCA prevented the increase in blood pressure. Vascular Na+-pump activity in the DOCA-treated group was reduced by 20% compared to all other groups. The AV3V lesions prevented the suppression of Na+-pump activity caused by DOCA treatment. Suppression of vascular Na+-pump activity was due to a humoral substance since Na+-pump activity of tail arteries from control rats incubated in plasma from DOCA-salt treated rats was suppressed by 25% when compared to those incubated in control plasma. Our findings support the hypothesis that a circulating pressor substance is at least partially responsible for the development of DOCA-salt hypertension and that the mechanism by which AV3V lesions prevent DOCA hypertension may be through the interruption of secretion, transport, or synthesis of this factor.

This article has been cited by other articles:

				M. Nishimura, K. Ohtsuka, N. Iwai, H. Takahashi, and M. Yoshimura Regulation of brain renin-angiotensin system by benzamil-blockable sodium channels Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1416 - R1424. [Abstract] [Full Text] [PDF]

				L. Michea, V. Valenzuela, I. Bravo, A. Schuster, and E. T. Marusic Adrenal-dependent modulation of the catalytic subunit isoforms of the Na+-K+-ATPase in aorta Am J Physiol Endocrinol Metab, December 1, 1998; 275(6): E1072 - E1081. [Abstract] [Full Text] [PDF]

				M. Nishimura, K. Ohtsuka, A. Nanbu, H. Takahashi, and M. Yoshimura Benzamil blockade of brain Na+ channels averts Na+-induced hypertension in rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R635 - R644. [Abstract] [Full Text] [PDF]

				X. Liu, L. J. Hymel, and E. Songu-Mize Role of Na+ and Ca2+ in stretch-induced Na+-K+-ATPase alpha -subunit regulation in aortic smooth muscle cells Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H83 - H89. [Abstract] [Full Text] [PDF]

				F. J. HADDY Sodium-Potassium Pump in Low-Renin Hypertension Ann Intern Med, May 1, 1983; 98(5_Part_2): 781 - 784. [Abstract] [PDF]